The Global Market For Generic Sterile Injectables To Double In Value By 2032

According to new analysis at insightSLICE, the global generic sterile injectable market size was estimated to be $79.95 billion in 2022 and is...

Related Keywords

United States ,American ,America ,Aditi Shivarkar ,Asia Pacific ,Development Of Biosimilars ,Advancements In Manufacturing Technology ,Development Of Complex Oncology Drugs ,Complex Oncology Drugs ,Personalized Medicine ,New Therapeutic Indications ,Manufacturing Technology ,North American ,North America ,Toward Outpatient Settings ,Portfolio Expansion ,